Sage Revell is an associate in the Firm's Corporate Practice Group and a member of the Firm's Global Life Sciences Practice Group. She advises on a wide range of corporate and commercial matters, including national and cross-border mergers and acquisitions, venture capital, private equity, corporate re-organizations, and other general commercial matters.
Sage works closely with Brown Rudnick’s US offices as corporate counsel in transactions involving UK concerns.
Prior to joining Brown Rudnick, Sage was an associate at a major international law firm in their Corporate/Private Equity team.
Sage speaks English and French.
Sage's key areas of experience are:
Representing both investors and investee companies in connection with numerous venture capital and private equity transactions, with particular focus on life sciences, technology, and impact investment sectors.
Negotiating on behalf of buyers and sellers on numerous cross-border M&A transactions involving the acquisition or sale of companies globally.
Advising family offices and other private investors on a broad range of cross-border transactions, with particular focus on the real estate sector.
In recent years, Sage has worked on the following matters:
Life Sciences / Technology / M&A
Advised Bio-Rad Laboratories Inc., a global leader in developing, manufacturing, and marketing products for life sciences research and clinical trials, in its various investments (seed and several follow-on rounds) into a Scottish life sciences company which is working to develop and commercialize a test that helps detect the ability of (UTIs) to resist antibiotics.
Advised the management team of GreenSteam Vessel Optimisation (UK) Ltd (a marine data intelligence company) on the company’s reorganization, the securing of equity finance from P/F Royndin, a Faroe Islands-based investment firm, and a loan facility from BP Castrol.
Advised an independent French company specializing in packaging solutions for medical devices on an asset sale to one of the world’s largest independent pharmaceutical companies for over €50 million.
Acted for a family office in its £7 million investment into an asset management company offering ETFs primarily linked to Europe’s credit markets, structured in two tranches, with the second one being made at the option of the investor on approval from the FCA.
Advised for Candela Medical on various corporate restructuring issues.
Acted for the sellers on the sale of Katsouris Limited, a Mediterranean food products business to Cranswick PLC for over £50 million.
Acted for Victoria PLC in various private acquisitions to expand its portfolio in Europe.
Real Estate Transactions
Acted for Queensgate Investments on its c. £1 billion acquisition of four central London hotels from the Grange Hotels group and leasing to the Fattal Group.
Acted for Queensgate Investments on its sale of London Executive Offices, a serviced office business, to a family office for £475 million.
Acted for a New York-based family office in its acquisition of a luxury hotel located on the island of Saint Martin in the Caribbean for over €35 million.
Acted for a family office in its acquisition of a large shopping center in Germany for over €100 million.
Acted for a high net worth individual in his investment (by way of term loan facility) into a luxury property development.
Acted for a hotel investment company (backed by a predominant PE fund) in a bridge financing and option agreement to acquire a hotel in Shoreditch, London.
Other General Corporate / Pro Bono
Provided corporate support on various restructuring deals, including the Lehman Bros liquidation.
Provided ongoing corporate support to the litigation team on a high profile real estate dispute, including negotiations in Dubai in February 2020.
Extensive pro bono efforts including corporate governance work for the anti-doping charity FairSport, the directors of which produced the Oscar award winning Netflix documentary ‘Icarus’.
BPP Law School, London – GDL and LPC, 2012
King’s College London – BSc in Mathematics, 2010
Solicitor, England & Wales
© 2021 Brown Rudnick LLP. Attorney Advertising